In the current modern era of unhealthy lifestyles, non-alcoholic fatty liver disease (NAFLD) is
the most prevalent liver disease and has become a serious global health problem. To date …

Patients with type 2 diabetes mellitus (T2DM) are exposed to non-alcoholic fatty liver
disease (NAFLD), a comorbidity associated with cardiovascular disease and chronic kidney …

Non-alcoholic fatty liver disease (NAFLD) is one of the main causes of liver disease,
specifically chronic liver disease. Type 2 diabetes (T2DM) is associated with the risk of …

Abstract Background and Aim Sodium glucose cotransporter 2 inhibitors (SGLT‐2i), by way
of their unique mode of action, present an attractive strategy for the treatment of type 2 …

Affecting one fourth of the global population, non‐alcoholic fatty liver disease (NAFLD) is the
commonest chronic liver disorder. It encompasses the simple liver fat accumulation to more …

Aims Non‐alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver
disease in Western countries and a common comorbidity with type 2 diabetes (T2D). It lacks …

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent cause of chronic liver disease
worldwide. NAFLD is considerably more frequent in patients with type 2 diabetes mellitus …

Nonalcoholic fatty liver disease (NAFLD) is considered the most prevalent chronic hepatic
disease, as it has been estimated that one of four individuals in the general population has …

Non-alcoholic fatty liver disease (NAFLD) is a group of metabolic liver illnesses that lead to
accumulation of liver fat mainly due to excessive nutrition. It is closely related to insulin …

Non-alcoholic fatty liver disease (NAFLD) is an 'umbrella'term, comprising a spectrum
ranging from benign, liver steatosis to non-alcoholic steatohepatitis, liver fibrosis and …